BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9142969)

  • 1. Rationale for the use of bisphosphonates in breast cancer.
    Kanis JA
    Acta Oncol; 1996; 35 Suppl 5():61-7. PubMed ID: 9142969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone and cancer: pathophysiology and treatment of metastases.
    Kanis JA
    Bone; 1995 Aug; 17(2 Suppl):101S-105S. PubMed ID: 8579890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osteolytic metastases of breast cancer and biphosphonates].
    Lortholary A; Alleaume C; Pein F; Larra F
    Rev Med Interne; 1992; 13(3):238-42. PubMed ID: 1410908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone.
    Biermann WA; Cantor RI; Fellin FM; Jakobowski J; Hopkins L; Newbold RC
    Bone; 1991; 12 Suppl 1():S37-42. PubMed ID: 1720013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for the use of bisphosphonates in bone metastases.
    Kanis JA; McCloskey EV; Taube T; O'Rourke N
    Bone; 1991; 12 Suppl 1():S13-8. PubMed ID: 1954047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pamidronate in the treatment of bone metastases from breast cancer].
    Nagykálnai T; Landherr L; Zatkóné GP; Gyuricska A
    Magy Onkol; 2002; 46(3):225-33. PubMed ID: 12368918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of skeletal disease in breast cancer with clodronate.
    Paterson AH; Ernst DS; Powles TJ; Ashley S; McCloskey EV; Kanis JA
    Bone; 1991; 12 Suppl 1():S25-30. PubMed ID: 1720012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates in multiple myeloma.
    Kanis JA; McCloskey EV
    Cancer; 2000 Jun; 88(12 Suppl):3022-32. PubMed ID: 10898347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimising treatment of bone metastases by Aredia(TM) and Zometa(TM).
    Coleman RE
    Breast Cancer; 2000; 7(4):361-9. PubMed ID: 11114866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone.
    Coukell AJ; Markham A
    Drugs Aging; 1998 Feb; 12(2):149-68. PubMed ID: 9509293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bisphosphonates and bone metastases].
    Lortholary A; Jadaud E; Berthaud P
    Bull Cancer; 1999 Sep; 86(9):732-8. PubMed ID: 10519966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of the role of bisphosphonates in metastatic disease.
    Ross JR; Saunders Y; Edmonds PM; Patel S; Wonderling D; Normand C; Broadley K
    Health Technol Assess; 2004; 8(4):1-176. PubMed ID: 14960258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
    Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
    J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates in the treatment of metastatic breast cancer.
    Body JJ
    J Mammary Gland Biol Neoplasia; 2001 Oct; 6(4):477-85. PubMed ID: 12013536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic effect of bisphosphonates on bone pain in breast cancer patients: a review article.
    Strang P
    Acta Oncol; 1996; 35 Suppl 5():50-4. PubMed ID: 9142965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of metastatic bone disease in breast cancer: bisphosphonates.
    Diel IJ; Solomayer EF; Bastert G
    Clin Breast Cancer; 2000 Apr; 1(1):43-51. PubMed ID: 11899389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints.
    Major PP; Cook R
    Am J Clin Oncol; 2002 Dec; 25(6 Suppl 1):S10-8. PubMed ID: 12562046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates and breast carcinoma.
    Lipton A
    Cancer; 1997 Oct; 80(8 Suppl):1668-73. PubMed ID: 9362434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.